Sury Center Treatment Facility Management Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 0.50 M
as on 19-12-2024
- Company Age 6 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 189.57%
(FY 2020)
- Profit 152.98%
(FY 2020)
- Ebitda 272.63%
(FY 2020)
- Net Worth 88.81%
(FY 2020)
- Total Assets 61.44%
(FY 2020)
About Sury Center Treatment Facility Management
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Meghana Kore and Prutha Edwankar serve as directors at the Company.
- CIN/LLPIN
U93090PN2018PTC180461
- Company No.
180461
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sury Center Treatment Facility Management?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prutha Edwankar  | Director | 03-Jul-2024 | Current |
| Meghana Kore | Director | 29-Nov-2018 | Current |
Financial Performance of Sury Center Treatment Facility Management.
Sury Center Treatment Facility Management Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 189.57% increase. The company also saw a substantial improvement in profitability, with a 152.98% increase in profit. The company's net worth Soared by an impressive increase of 88.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sury Center Treatment Facility Management?
In 2020, Sury Center Treatment Facility Management had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surya Center Treatment Facility Private LimitedActive 2 years 2 daysMeghana Kore and Prutha Edwankar are mutual person
- Wisefinch Robotics And Automation Private LimitedActive 3 years 4 months
Prutha Edwankar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sury Center Treatment Facility Management?
Sury Center Treatment Facility Management has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sury Center Treatment Facility Management, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sury Center Treatment Facility Management's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
